The Precision Peptide Company Inc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Pratapvir Sandhu
- Full Time Employees
- 2
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 8035-130th Street Surrey BC Canada V3W 0H7
- IPO Date
- Aug 25, 2022
- Website
- pangeafood.com
- Similar Companies
- Business
- Pangea Natural Foods Inc. (PNGAF) manufactures and distributes plant-based food products and innovative wellness solutions focused on clean-label nutrition and non-injectable peptide therapies in North America. The company offers plant-based patties; old fashioned ghee made from grass-fed organic New Zealand butter; energy gel with apple-based honey for rapid nutrient delivery; vitality, sunshine, and greens blends; plant-based recovery drinks; munchie mix; and co-packing, manufacturing, supply-chain, and distribution services for third-party food and beverage companies; through its subsidiary Amino Innovations Corp., it provides peptide therapies including BPC for rapid muscle and joint recovery, and products targeting stress management, gut health, longevity, hair health, skin repair, sleep health, and immune support via oral and topical delivery systems. Products reach consumers through company websites, over 500 retail outlets across Canada and the United States such as Loblaws, Sobeys, Whole Foods, Save-On-Foods, Choices Markets, and select Air Canada and WestJet flights, as well as wholesale networks. Founded in 2021 and headquartered in Vancouver, British Columbia, Canada, with operations in Surrey, British Columbia, the company serves the packaged foods and consumer wellness sectors targeting health-conscious individuals and growing food brands. In Q2 2025, Pangea completed the acquisition of Amino Innovations Corp. to expand into peptide-based wellness products and needle-less delivery systems; it secured CAD 500,000 in development capital through a private placement in January 2025 and anticipates receiving CAD 2.9 million in additional funding; earlier in 2024, it launched co-packing services for scalability and cost savings while opting not to acquire Glory Juice Co. to prioritize core brand expansion.
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares
The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Appoints Certified Peptide Therapist and Integrative Health Coach Diane Stafrace to Advisory Board
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine
The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland
The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC
The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances